Rhumbline Advisers Omeros Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Omeros Corp stock. As of the latest transaction made, Rhumbline Advisers holds 107,659 shares of OMER stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,659

Previous 111,778 3.68%

Holding current value

$1.11 Million

Previous $453,000 5.74%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.54 - $5.47 $14,581 - $22,530	-4,119 Reduced 3.68%	107,659 $427,000
Q2 2024 Aug 01, 2024	BUY	$3.04 - $4.23 $19,562 - $27,220	6,435 Added 6.11%	111,778 $453,000
Q1 2024 May 09, 2024	SELL	$2.88 - $4.89 $10,771 - $18,288	-3,740 Reduced 3.43%	105,343 $363,000
Q4 2023 Feb 08, 2024	BUY	$1.08 - $3.63 $20,405 - $68,585	18,894 Added 20.95%	109,083 $356,000
Q3 2023 Nov 09, 2023	SELL	$2.81 - $5.69 $2,953 - $5,980	-1,051 Reduced 1.15%	90,189 $263,000
Q2 2023 Aug 08, 2023	BUY	$4.45 - $7.57 $406,018 - $690,686	91,240 New	91,240 $496,000
Q2 2022 Aug 11, 2022	SELL	$1.92 - $6.28 $138,533 - $453,120	-72,153 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.07 - $7.2 $4,857 - $6,897	958 Added 1.35%	72,153 $434,000
Q4 2021 Feb 10, 2022	SELL	$5.67 - $8.54 $6,582 - $9,914	-1,161 Reduced 1.6%	71,195 $458,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $33,366 - $40,587	-2,490 Reduced 3.33%	72,356 $998,000
Q2 2021 Aug 05, 2021	BUY	$14.81 - $19.13 $83,365 - $107,682	5,629 Added 8.13%	74,846 $1.11 Million
Q1 2021 May 06, 2021	SELL	$14.52 - $23.53 $95,527 - $154,803	-6,579 Reduced 8.68%	69,217 $1.23 Million
Q4 2020 Feb 10, 2021	BUY	$10.14 - $15.19 $63,263 - $94,770	6,239 Added 8.97%	75,796 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$9.57 - $21.32 $120,294 - $267,992	-12,570 Reduced 15.31%	69,557 $703,000
Q2 2020 Aug 13, 2020	BUY	$12.21 - $16.99 $138,791 - $193,125	11,367 Added 16.06%	82,127 $1.21 Million
Q1 2020 May 06, 2020	SELL	$9.03 - $19.72 $42,639 - $93,117	-4,722 Reduced 6.26%	70,760 $946,000
Q4 2019 Feb 05, 2020	BUY	$13.01 - $17.15 $8,092 - $10,667	622 Added 0.83%	75,482 $1.06 Million
Q3 2019 Oct 23, 2019	SELL	$14.55 - $20.56 $6,823 - $9,642	-469 Reduced 0.62%	74,860 $1.22 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $164,190 - $214,760	-10,946 Reduced 12.69%	75,329 $1.18 Million
Q1 2019 May 01, 2019	BUY	$11.65 - $17.72 $163,472 - $248,647	14,032 Added 19.42%	86,275 $1.5 Million
Q4 2018 Jan 31, 2019	BUY	$10.72 - $16.73 $327,463 - $511,051	30,547 Added 73.26%	72,243 $805,000
Q3 2018 Nov 07, 2018	SELL	$17.73 - $26.69 $54,076 - $81,404	-3,050 Reduced 6.82%	41,696 $1.02 Million
Q2 2018 Aug 06, 2018	BUY	$10.79 - $24.44 $32,596 - $73,833	3,021 Added 7.24%	44,746 $812,000
Q1 2018 May 02, 2018	BUY	$9.0 - $20.16 $3,645 - $8,164	405 Added 0.98%	41,725 $466,000
Q4 2017 Feb 09, 2018	SELL	$13.26 - $22.86 $80,779 - $139,263	-6,092 Reduced 12.85%	41,320 $803,000
Q3 2017 Nov 06, 2017	BUY	$19.76 - $24.9 $936,861 - $1.18 Million	47,412	47,412 $1.03 Million

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $647M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Omeros Corp Transaction History